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  Serum fucose is known to increase in malignant diseases． we measured the serum
fucose of the patients with urogenital diseases， and found that the level of serum fucose was
elevated beyond the normal limit in patients having progressed stage of tumors， pyelonephritis，
marked infiammation such as prostatitis and in patients within t month postoperation．
  Patients having canごer・us cachexia had d三st三nctly elevateCl serum fuc・se while patients
having prostatic cahcer sometimes had normal serum fucose even in the progressive stage of
cancer．
  In general， the elevation of serum fucose correlated with that of the erythrocyte sedim－
entatlon rate．
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 age 28－92（mean 66）
Benign cases
  46 male 〈   14 female
 age 15一一85 （mean 53）
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X 12＝ mg of fucose／ 100 ml of serum
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量2翼dilU曾ion foc？or
      Fig．3．フコース濃度の算出式
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Table 3． Mean serum fucose value of malignancies
Turnor type
Meon serum fucose No．
 value
mgltOOml serum CaSeS
Mean serum fueose No．
 value
































Tota l 1 2．8 ± 2．6 57 19土O．4 50
Table 4． Mean serum fucose value of benign diseases
Diseases





































Tota I 12，6± 2，7 60 1．9士O，5 49
Acute loflammatory
  d．iseases Others
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 Fig． 4． Correlation between the serum fycose value and．
         the erYthrocyte sedimentation rate in benign cases
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Fig． 5． Correlation between the serum fucose
       ．the erythrQcyte sedimeptation rate in
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  acute prostatitis十pyelonephritis
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Mdr． （1981｝ J6n， F6b． Mdr． ｛1981）
    Jan． Feb． Mar，
S．T． 54y．o． male
Renal pelvic tumor （stage D）
   （died on 5 March 1981）
            Fig． 9
Ja”． Feb． Mar．
T． K． 50 y．o． male
Renal tumor （stage D）
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